Article Versions Notes

Abdel-Rahman AA-H, Shaban AKF, Nassar IF, EL-Kady DS, Ismail NSM, Mahmoud SF, Awad HM, El-Sayed WA. Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity. Molecules. 2021; 26(13):3923. https://doi.org/10.3390/molecules26133923

Abdel-Rahman, Adel A.-H., Amira K. F. Shaban, Ibrahim F. Nassar, Dina S. EL-Kady, Nasser S. M. Ismail, Samy F. Mahmoud, Hanem M. Awad, and Wael A. El-Sayed. 2021. "Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity" Molecules 26, no. 13: 3923. https://doi.org/10.3390/molecules26133923

Abdel-Rahman, A. A.-H., Shaban, A. K. F., Nassar, I. F., EL-Kady, D. S., Ismail, N. S. M., Mahmoud, S. F., Awad, H. M., & El-Sayed, W. A. (2021). Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity. Molecules, 26(13), 3923. https://doi.org/10.3390/molecules26133923